MARCH 27
Days
- :
Hrs
- :
Min
- :
Sec
ePoster Gallery
P150: The use of radar-guided localization to identify metastatic melanoma after neoadjuvant therapy
Michelle Dugan MD
Moffitt Cancer Center
P151: T-VEC Shifts CD8 Phenotype to Reverse Anti-PD1 Resistance
Aparna Vancheswaran MD
Memorial Sloan Kettering Cancer Center
P152: 900 patients later: outcomes of cytoreduction and heated intraperitoneal chemotherapy for appendiceal neoplasms
Heidy Cos MD
Atrium Health Wake Forest Baptist Medical Center
P153: A multi-state cohort study of hospital utilization and treatment modality for malignant small bowel obstruction
Rachael Acker MD
University of Pennsylvania
P154: A Novel Pre-clinical Model for Peritoneal Metastasis Utilizing Cross-Polarization Imaging for Independent Scoring
Vashti Bandy
VIRGINIA COMMONWEALTH UNIVERSITY
P155: Appendiceal cancers display immunosuppressed microenvironment and mucin infiltration on multiplex immunofluorescence analysis
Carlos Ayala-Navarro MD, PhD
Moffitt Cancer Center
P156: Characteristics and Outcomes of External Referral Patients Undergoing Cytoreductive Surgery at an International Peritoneal Surface Malignancy Program
Edward Joseph
Allegheny General Hospital
P157: Clinical outcomes of high-grade appendiceal mucinous neoplasms
Ashlee Seldomridge MD
The University of Texas MD Anderson Cancer Center
P159: Decision Regret and Quality of Life in Caregivers of Patients with Appendiceal Cancer Undergoing Hyperthermic Intraperitoneal Chemotherapy
Lauren Marek MD
P159: Defining the Surgical Oncology Experience During General Surgery Residency: A Multi-Institutional Study from the US ROPE Consortium
Anna Reagan MD
University of Kentucky
P160: Experiences and Decisional Outcomes After Cytoreductive Surgery for Peritoneal Surface Malignancy: A Survey from the DECISIVE Study
Elizabeth Godfrey MD
Yale New Haven Health/Yale School of Medicine
P161: External Validation of Basingstoke Prognostic Nomogram in Patients with Mucinous Appendix Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Sergei Iugai MD
Mercy Medical Center
P162: Feasibility and Accuracy of Sentinel Lymph Node Biopsy (SLNB) in Primary Epithelial Ovarian Cancer (PEOC) (FIGO Stage I-III) - A Prospective Pilot Study
Ashutosh Mishra MCh, FACS
All India Institute of Medical Sciences, New Delhi
P164: Genomic alterations in the skeletal muscle of patients with appendiceal peritoneal carcinomatosis
Vignesh Vudatha
VCU Health
P165: Histology of Recurrent Mucinous Appendiceal Cancer after CRS-HIPEC for Low Grade Peritoneal Metastases
Sohini Khan MD
UC San Diego
P166: Impact of Peritoneal Carcinomatosis and Malignant Ascites on the Outcome of Malignant Bowel Obstruction: Secondary Analysis of SWOG S1316
Kristen Dougherty MD
University of North Carolina - Chapel Hill
P167: Impact of Systematic Discontinuation of Mitomycin C HIPEC for Colorectal Peritoneal Metastasis on Oncologic Outcomes at an NCI Cancer Center
Mustafa Raoof MD
City of Hope Medical Center
P169: Inhibiting coagulation factor XIIIa in colorectal cancer peritoneal metastasis
Savannah Gregg
Central Virginia VA Healthcare System, Richmond Institute for Veterans Research